Vinflunine as second-line therapy for advanced urothelial carcinoma: Russian observational study

Objective: to assess safety, responses rate and duration, progression-free and overall survival in patients with advanced urothelial carcinoma receiving vinflunine as second-line therapy in routine clinical practice, after additional patient recruitment.Materials and methods. This retrospective obse...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: M. I. Volkova, V. A. Chernyaev, V. B. Matveev, B. Ya. Alekseev, K. M. Nyushko, L. V. Bolotina, A. L. Kornietskaya, A. A. Paichadze, S. Ch. Maykoparova, L. A. Ryadinskaya, S. N. Kabanov, A. E. Storozhakova, N. Yu. Samaneva, A. V. Shcherbinin, S. A. Varlamov, I. S. Varlamov, E. I. Kopyl’tsov, A. A. Lebedinets, M. V. Odintsova, S. S. Kolesnikov, E. V. Karabina
Format: Artigo
Jezik:Russo
Izdano: ABV-press 2017-09-01
Serija:Onkourologiâ
Teme:
advanced urothelial carcinoma
second-line therapy
vinfluninel
Online pristup:https://oncourology.abvpress.ru/oncur/article/view/736
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items